Comparative Pharmacology
Head-to-head clinical analysis: AMINOSYN PF 7 versus CLINIMIX E 5 20 SULFITE FREE W ELECT IN 20 DEXTROSE W CALCIUM IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMINOSYN PF 7 versus CLINIMIX E 5 20 SULFITE FREE W ELECT IN 20 DEXTROSE W CALCIUM IN PLASTIC CONTAINER.
AMINOSYN-PF 7% vs CLINIMIX E 5/20 SULFITE FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aminosyn-PF 7% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, thereby maintaining nitrogen balance and supporting tissue repair and growth in parenteral nutrition.
Parenteral nutrition providing essential amino acids, electrolytes, and dextrose for caloric support and protein synthesis.
Intravenous infusion; typical adult dose: 1-2 g amino acids/kg/day (e.g., 14-28 mL/kg/day for 7% solution) as part of parenteral nutrition. Infusion rate not to exceed 0.1 g amino acids/kg/hour.
Intravenous. Adult: 2 L/day (providing 100 g protein and 400 g dextrose) or as per metabolic needs. Rate: 100 mL/hr initially, adjusted based on tolerance and glucose monitoring.
None Documented
None Documented
As a mixture of amino acids, individual amino acids have half-lives ranging from minutes to hours; clinically, continuous infusion maintains steady state.
Amino acids: 0.5-2 hours (rapid clearance dependent on metabolic demand). Glucose: ~2-4 hours in euglycemic states. No single terminal half-life due to mixture.
Amino acids are primarily cleared by metabolism; less than 10% is excreted unchanged in urine.
Components are primarily metabolized; nitrogen waste excreted renally as urea (85-90%), with minimal biliary/fecal elimination (<5%). Electrolytes and dextrose are fully metabolized or excreted renally.
Category C
Category C
Parenteral Nutrition Solution
Parenteral Nutrition Solution